Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2019.5006
Abstract: Advances in molecular testing have ushered in the new era of precision medicine. The 2018 publication of the TAILORx trial helped refine the use of genetic expression assays, specifically the 21-gene recurrence score, in assigning…
read more here.
Keywords:
medicine;
nccn guidelines;
breast cancer;
updates breast ... See more keywords